{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:52:09Z","timestamp":1793317929900,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82222075"],"award-info":[{"award-number":["82222075"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174215"],"award-info":[{"award-number":["82174215"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174364"],"award-info":[{"award-number":["82174364"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374420"],"award-info":[{"award-number":["82374420"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81822049"],"award-info":[{"award-number":["81822049"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jare.2024.02.008","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T20:19:52Z","timestamp":1708201192000},"page":"241-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Valerenic acid attenuates pathological myocardial hypertrophy by promoting the utilization of multiple substrates in the mitochondrial energy metabolism"],"prefix":"10.1016","volume":"68","author":[{"given":"Tiantian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianbin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jare.2024.02.008_b0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.jare.2024.02.008_b0010","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ejhf.1715","article-title":"Hypertrophic cardiomyopathy: the future of treatment","volume":"22","author":"Tuohy","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.jare.2024.02.008_b0015","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.jare.2024.02.008_b0020","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.jare.2024.02.008_b0025","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/cvr\/cvz045","article-title":"Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency","volume":"115","author":"Ho","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jare.2024.02.008_b0030","doi-asserted-by":"crossref","unstructured":"Yavari A, Bellahcene M, Bucchi A, Sirenko S, Pinter K, Herring N, et al. Mammalian \u03b32 AMPK regulates intrinsic heart rate. 2017;8(1):1258.","DOI":"10.1038\/s41467-017-01342-5"},{"issue":"8","key":"10.1016\/j.jare.2024.02.008_b0035","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/CIRCULATIONAHA.117.029703","article-title":"MicroRNA-146a as a regulator of cardiac energy metabolism","volume":"136","author":"Demkes","year":"2017","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jare.2024.02.008_b0040","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","article-title":"Cardiac metabolism in heart failure: implications beyond ATP production","volume":"113","author":"Doenst","year":"2013","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.jare.2024.02.008_b0045","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.apsb.2020.10.007","article-title":"Energy metabolism disorders and potential therapeutic drugs in heart failure","volume":"11","author":"He","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jare.2024.02.008_b0050","doi-asserted-by":"crossref","unstructured":"Murashige D, Jang C. Comprehensive quantification of fuel use by the failing and nonfailing human heart. 2020;370(6514):364\u20138.","DOI":"10.1126\/science.abc8861"},{"issue":"1","key":"10.1016\/j.jare.2024.02.008_b0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCRESAHA.118.312017","article-title":"Metabolic coordination of physiological and pathological cardiac remodeling","volume":"123","author":"Gibb","year":"2018","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.jare.2024.02.008_b0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cmet.2020.12.003","article-title":"The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure","volume":"33","author":"Cluntun","year":"2021","journal-title":"Cell Metab"},{"issue":"13","key":"10.1016\/j.jare.2024.02.008_b0065","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1073\/pnas.96.13.7473","article-title":"A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders","volume":"96","author":"Leone","year":"1999","journal-title":"PNAS"},{"key":"10.1016\/j.jare.2024.02.008_b0070","doi-asserted-by":"crossref","unstructured":"Montaigne D, Butruille L. PPAR control of metabolism and cardiovascular functions. 2021;18(12):809\u201323.","DOI":"10.1038\/s41569-021-00569-6"},{"key":"10.1016\/j.jare.2024.02.008_b0075","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.metabol.2018.07.004","article-title":"Sugar or fat: the metabolic choice of the trained heart","volume":"87","author":"Ferreira","year":"2018","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.jare.2024.02.008_b0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/cvr\/cvn001","article-title":"Cardiac hypertrophy is enhanced in PPAR alpha-\/- mice in response to chronic pressure overload","volume":"78","author":"Smeets","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jare.2024.02.008_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.730623","article-title":"Dapagliflozin mediates Plin5\/PPAR\u03b1 signaling axis to attenuate cardiac hypertrophy","volume":"12","author":"Yu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jare.2024.02.008_b0090","first-page":"120","article-title":"Ginsenoside Rb3 regulates energy metabolism and apoptosis in cardiomyocytes via activating PPAR\u03b1 pathway","author":"Chen","year":"2019","journal-title":"Biomed Pharmacoth = Biomed Pharmacoth"},{"key":"10.1016\/j.jare.2024.02.008_b0095","doi-asserted-by":"crossref","unstructured":"Wagner KD, Wagner N. PPARs and Myocardial Infarction. 2020;21(24).","DOI":"10.3390\/ijms21249436"},{"issue":"8","key":"10.1016\/j.jare.2024.02.008_b0100","first-page":"972","article-title":"PPARalpha in atherosclerosis and inflammation","volume":"1771","author":"Zandbergen","year":"2007","journal-title":"BBA"},{"issue":"2","key":"10.1016\/j.jare.2024.02.008_b0105","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2165\/00003495-199040020-00007","article-title":"A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia","volume":"40","author":"Balfour","year":"1990","journal-title":"Drugs"},{"issue":"21","key":"10.1016\/j.jare.2024.02.008_b0110","doi-asserted-by":"crossref","first-page":"e20390","DOI":"10.1097\/MD.0000000000020390","article-title":"Fenofibrate monotherapy-induced rhabdomyolysis in a patient with post-pancreatitis diabetes mellitus: a rare case report and a review of the literature","volume":"99","author":"Zhou","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"14","key":"10.1016\/j.jare.2024.02.008_b0115","doi-asserted-by":"crossref","first-page":"e0318","DOI":"10.1097\/MD.0000000000010318","article-title":"Fenofibrate monotherapy-induced rhabdomyolysis in a patient with hypothyroidism: a rare case report and literature review","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jare.2024.02.008_b0120","unstructured":"Hao Fan SY, Xiaofei Liang, Guoqing Wu, Li Zhang, Wenli Huang, Huawei Zhang, Xiaomei Song. Research progress in chemical constituents in valeriana officinalis and their physiological activity. J Liaon Univ TCM 2019;21(12):172\u20135."},{"issue":"03","key":"10.1016\/j.jare.2024.02.008_b0125","first-page":"11","article-title":"Effect of valeriana officinalis L extract on correlated electrophysiological paramaters of ventricular arrhythmias induced by congestive heart failure in rabbit","volume":"26","author":"Shuhong Yang","year":"2016","journal-title":"Chin J Microcirc"},{"issue":"05","key":"10.1016\/j.jare.2024.02.008_b0130","first-page":"639","article-title":"Protection of valeriana officinalis L extract preconditioning on ischemia-reperfusion injury in rat hearts in vitro","volume":"33","author":"Shuhong Yang","year":"2012","journal-title":"Med J Wuhan Univ"},{"key":"10.1016\/j.jare.2024.02.008_b0135","doi-asserted-by":"crossref","first-page":"e70280","DOI":"10.5209\/mbot.70280","article-title":"Updating the biological interest of 'Valeriana officinalis'","volume":"42","author":"S\u00e1nchez","year":"2021","journal-title":"Med Botany"},{"key":"10.1016\/j.jare.2024.02.008_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173086","article-title":"Valeric acid lowers arterial blood pressure in rats","volume":"877","author":"Onyszkiewicz","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.jare.2024.02.008_b0145","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/cvr\/cvz205","article-title":"HuR regulates phospholamban expression in isoproterenol-induced cardiac remodelling","volume":"116","author":"Hu","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jare.2024.02.008_b0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cbi.2019.04.024","article-title":"Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT\/GSK-3\u03b2 signaling pathway","volume":"307","author":"Shang","year":"2019","journal-title":"Chem Biol Interact"},{"issue":"9","key":"10.1016\/j.jare.2024.02.008_b0155","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1038\/s41418-020-0523-2","article-title":"Selective targeting of ubiquitination and degradation of PARP1 by E3 ubiquitin ligase WWP2 regulates isoproterenol-induced cardiac remodeling","volume":"27","author":"Zhang","year":"2020","journal-title":"Cell Death Differ"},{"issue":"10","key":"10.1016\/j.jare.2024.02.008_b0160","first-page":"Cd009580","article-title":"Fibrates for secondary prevention of cardiovascular disease and stroke","volume":"2015","author":"Wang","year":"2015","journal-title":"Cochrane Datab Syst Rev"},{"key":"10.1016\/j.jare.2024.02.008_b0165","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1475-2840-11-125","article-title":"Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction","volume":"11","author":"Tenenbaum","year":"2012","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.jare.2024.02.008_b0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.carpath.2015.09.008","article-title":"Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1","volume":"25","author":"Parry","year":"2016","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jare.2024.02.008_b0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lfs.2015.01.015","article-title":"Effects of ERK1\/2\/PPAR\u03b1\/SCAD signal pathways on cardiomyocyte hypertrophy induced by insulin-like growth factor 1 and phenylephrine","volume":"124","author":"Huang","year":"2015","journal-title":"Life Sci"},{"key":"10.1016\/j.jare.2024.02.008_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114841","article-title":"Qishen granule (QSG) exerts cardioprotective effects by inhibiting NLRP3 inflammasome and pyroptosis in myocardial infarction rats","volume":"285","author":"Chen","year":"2022","journal-title":"J Ethnopharmacol"},{"issue":"11","key":"10.1016\/j.jare.2024.02.008_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101727","article-title":"PPAR\u03b1 ligand-binding domain structures with endogenous fatty acids and fibrates","volume":"23","author":"Kamata","year":"2020","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.jare.2024.02.008_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106012","article-title":"Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking","volume":"56","author":"Yu","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"16","key":"10.1016\/j.jare.2024.02.008_b0195","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J Comput Chem"},{"key":"10.1016\/j.jare.2024.02.008_b0200","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"9","key":"10.1016\/j.jare.2024.02.008_b0205","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1021\/ct500487h","article-title":"Coarse-graining of TIP4P\/2005, TIP4P-Ew, SPC\/E, and TIP3P to monatomic anisotropic water models using relative entropy minimization","volume":"10","author":"Lu","year":"2014","journal-title":"J Chem Theory Comput"},{"issue":"20","key":"10.1016\/j.jare.2024.02.008_b0210","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1063\/1.1808117","article-title":"A modified TIP3P water potential for simulation with Ewald summation","volume":"121","author":"Price","year":"2004","journal-title":"J Chem Phys"},{"issue":"1","key":"10.1016\/j.jare.2024.02.008_b0215","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0009-2614(01)00393-1","article-title":"Particle mesh Ewald method for three-dimensional systems with two-dimensional periodicity","volume":"340","author":"Kawata","year":"2001","journal-title":"Chem Phys Lett"},{"issue":"14","key":"10.1016\/j.jare.2024.02.008_b0220","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.118.037803","article-title":"Lin28a regulates pathological cardiac hypertrophic growth through Pck2-mediated enhancement of anabolic synthesis","volume":"139","author":"Ma","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jare.2024.02.008_b0225","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","article-title":"HIF-1\u03b1 pathway: role, regulation and intervention for cancer therapy","volume":"5","author":"Masoud","year":"2015","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"10.1016\/j.jare.2024.02.008_b0230","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI38331","article-title":"Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice","volume":"120","author":"Ahuja","year":"2010","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.jare.2024.02.008_b0235","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/er.2018-00064","article-title":"Molecular actions of PPAR\u03b1 in lipid metabolism and inflammation","volume":"39","author":"Bougarne","year":"2018","journal-title":"Endocr Rev"},{"issue":"11","key":"10.1016\/j.jare.2024.02.008_b0240","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1016\/j.cell.2021.04.027","article-title":"Mitocytosis, a migrasome-mediated mitochondrial quality-control process","volume":"184","author":"Jiao","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jare.2024.02.008_b0245","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/CIRCRESAHA.117.311307","article-title":"Mitochondrial reactive oxygen species in lipotoxic hearts induce post-translational modifications of AKAP121, DRP1, and OPA1 that promote mitochondrial fission","volume":"122","author":"Tsushima","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.jare.2024.02.008_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2019.101006","article-title":"ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: an updated review","volume":"77","author":"Feng","year":"2020","journal-title":"Prog Lipid Res"},{"issue":"6","key":"10.1016\/j.jare.2024.02.008_b0255","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.cmet.2018.07.019","article-title":"Impairment of angiogenesis by fatty acid synthase inhibition involves mTOR malonylation","volume":"28","author":"Bruning","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2024.02.008_b0260","doi-asserted-by":"crossref","unstructured":"Aregger M, Lawson KA, Billmann M. Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism. 2020;2(6):499\u2013513.","DOI":"10.1038\/s42255-020-0211-z"},{"issue":"7678","key":"10.1016\/j.jare.2024.02.008_b0265","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature24057","article-title":"Glucose feeds the TCA cycle via circulating lactate","volume":"551","author":"Hui","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jare.2024.02.008_b0270","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/1535370217743919","article-title":"Pyruvate enhancement of cardiac performance: cellular mechanisms and clinical application","volume":"243","author":"Mallet","year":"2018","journal-title":"Exp Biol Med (Maywood)"},{"issue":"4","key":"10.1016\/j.jare.2024.02.008_b0275","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.molcel.2020.12.012","article-title":"Increased demand for NAD(+) relative to ATP drives aerobic glycolysis","volume":"81","author":"Luengo","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/j.jare.2024.02.008_b0280","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.yjmcc.2016.04.015","article-title":"Discovery of novel small molecule inhibitors of cardiac hypertrophy using high throughput, high content imaging","volume":"97","author":"Reid","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jare.2024.02.008_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105168","article-title":"Traditional Chinese medicine in cardiovascular drug discovery","volume":"160","author":"Leung","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jare.2024.02.008_b0290","doi-asserted-by":"crossref","unstructured":"Jugran AK, Rawat S. Valeriana jatamansi: an herbaceous plant with multiple medicinal uses. 2019;33(3):482\u2013503.","DOI":"10.1002\/ptr.6245"},{"key":"10.1016\/j.jare.2024.02.008_b0295","first-page":"20","article-title":"From Valeriana officinalis to cancer therapy: the success of a bio-sourced compound","author":"Malik","year":"2016","journal-title":"Biotechnol Agron Soc Environ"},{"issue":"3","key":"10.1016\/j.jare.2024.02.008_b0300","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41401-021-00678-5","article-title":"Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway","volume":"43","author":"Li","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jare.2024.02.008_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.crphys.2019.10.001","article-title":"Cardiac hypertrophy or failure? - A systematic evaluation of the transverse aortic constriction model in C57BL\/6NTac and C57BL\/6J substrains","volume":"1","author":"Zi","year":"2019","journal-title":"Curr Res Physiol"},{"issue":"1","key":"10.1016\/j.jare.2024.02.008_b0310","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1021\/pr500756u","article-title":"Metabolomic analysis of akt1-mediated muscle hypertrophy in models of diet-induced obesity and age-related fat accumulation","volume":"14","author":"Cheng","year":"2015","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jare.2024.02.008_b0315","doi-asserted-by":"crossref","unstructured":"Funakoshi S, Fernandes I, Mastikhina O, Wilkinson D, Tran T, Dhahri W, et al. Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells. 2021;12(1):3155.","DOI":"10.1038\/s41467-021-23329-z"},{"key":"10.1016\/j.jare.2024.02.008_b0320","doi-asserted-by":"crossref","unstructured":"Lee CQE, Kerouanton B, Chothani S, Zhang S, Chen Y, Mantri CK. Coding and non-coding roles of MOCCI (C15ORF48) coordinate to regulate host inflammation and immunity. 2021;12(1):2130.","DOI":"10.1038\/s41467-021-22397-5"},{"key":"10.1016\/j.jare.2024.02.008_b0325","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejmech.2019.01.067","article-title":"Role of PPAR receptor in different diseases and their ligands: physiological importance and clinical implications","volume":"166","author":"Mirza","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"7","key":"10.1016\/j.jare.2024.02.008_b0330","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: a consensus report","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"issue":"6785","key":"10.1016\/j.jare.2024.02.008_b0335","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/35013000","article-title":"Roles of PPARs in health and disease","volume":"405","author":"Kersten","year":"2000","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jare.2024.02.008_b0340","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijgo.2011.06.022","article-title":"Effects of valerian on the severity and systemic manifestations of dysmenorrhea","volume":"115","author":"Mirabi","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.jare.2024.02.008_b0345","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCRESAHA.115.306383","article-title":"Cardiac myocyte KLF5 regulates PPARA expression and cardiac function","volume":"118","author":"Drosatos","year":"2016","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.jare.2024.02.008_b0350","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1038\/s41598-017-02360-5","article-title":"Astragaloside IV alleviates heart failure via activating PPAR\u03b1 to switch glycolysis to fatty acid \u03b2-oxidation","volume":"7","author":"Dong","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.jare.2024.02.008_b0355","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.yjmcc.2007.11.006","article-title":"The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover","volume":"44","author":"O'Donnell","year":"2008","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"10.1016\/j.jare.2024.02.008_b0360","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/CIRCRESAHA.110.221713","article-title":"Preferential oxidation of triacylglyceride-derived fatty acids in heart is augmented by the nuclear receptor PPARalpha","volume":"107","author":"Banke","year":"2010","journal-title":"Circ Res"},{"issue":"20","key":"10.1016\/j.jare.2024.02.008_b0365","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1161\/CIRCULATIONAHA.114.011687","article-title":"Dietary fat supply to failing hearts determines dynamic lipid signaling for nuclear receptor activation and oxidation of stored triglyceride","volume":"130","author":"Lahey","year":"2014","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jare.2024.02.008_b0370","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCRESAHA.112.268128","article-title":"Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy","volume":"111","author":"Kolwicz","year":"2012","journal-title":"Circ Res"},{"issue":"3604","key":"10.1016\/j.jare.2024.02.008_b0375","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.143.3604.371","article-title":"Oxidation of carbon-14-labeled endogenous lipids by isolated perfused rat heart","volume":"143","author":"Shipp","year":"1964","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.jare.2024.02.008_b0380","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","article-title":"Metabolic remodelling in heart failure","volume":"15","author":"Bertero","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jare.2024.02.008_b0385","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fcvm.2018.00068","article-title":"Loss of metabolic flexibility in the failing heart","volume":"5","author":"Karwi","year":"2018","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"10.1016\/j.jare.2024.02.008_b0390","doi-asserted-by":"crossref","first-page":"e012673","DOI":"10.1161\/JAHA.119.012673","article-title":"Glucose metabolism in cardiac hypertrophy and heart failure","volume":"8","author":"Tran","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.jare.2024.02.008_b0395","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-0031-1298301","article-title":"Pharmacokinetics of valerenic acid in rats after intravenous and oral administrations","volume":"78","author":"Sampath","year":"2012","journal-title":"Planta Med"},{"key":"10.1016\/j.jare.2024.02.008_b0400","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/947619","article-title":"Chemical components and cardiovascular activities of Valeriana spp","volume":"2015","author":"Chen","year":"2015","journal-title":"Evid Based Complement Alternat Med"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123224000705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123224000705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:55:23Z","timestamp":1778835323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123224000705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":80,"alternative-id":["S2090123224000705"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2024.02.008","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valerenic acid attenuates pathological myocardial hypertrophy by promoting the utilization of multiple substrates in the mitochondrial energy metabolism","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2024.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}